{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T20:47:14Z","timestamp":1773089234667,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T00:00:00Z","timestamp":1518825600000},"content-version":"am","delay-in-days":322,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008659","name":"ECTRIMS-MAGNIMS Fellowship from The European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"publisher","award":["81571631"],"award-info":[{"award-number":["81571631"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Natural Science fund","award":["7162077"],"award-info":[{"award-number":["7162077"]}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Programme","doi-asserted-by":"publisher","award":["xx2013045"],"award-info":[{"award-number":["xx2013045"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008659","name":"ECTRIMS-MAGNIMS Fellowship from The European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"publisher","award":["81571631"],"award-info":[{"award-number":["81571631"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Natural Science Fund","award":["7162077"],"award-info":[{"award-number":["7162077"]}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Programme","doi-asserted-by":"publisher","award":["xx2013045"],"award-info":[{"award-number":["xx2013045"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.msard.2017.02.003","type":"journal-article","created":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T04:45:11Z","timestamp":1486442711000},"page":"58-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Comparison of brain and spinal cord magnetic resonance imaging features in neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody"],"prefix":"10.1016","volume":"13","author":[{"given":"Moli","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristofer","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Dong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2017.02.003_bib1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2377-13-33","article-title":"Modifications of longitudinally extensive transverse myelitis and brainstem lesions in the course of neuromyelitis optica (NMO): a population-based, descriptive study","volume":"13","author":"Asgari","year":"2013","journal-title":"BMC Neurol."},{"key":"10.1016\/j.msard.2017.02.003_bib2","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1177\/1352458509104585","article-title":"Neuromyelitis optica positive antibodies confer a worse course in relapsing-neuromyelitis optica in Cuba and French West Indies","volume":"15","author":"Cabrera-Gomez","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2017.02.003_bib3","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1468-1331.2011.03565.x","article-title":"Conventional brain MRI in neuromyelitis optica","volume":"19","author":"Cabrera-Gomez","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2017.02.003_bib4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1468-1331.2012.03867.x","article-title":"White matter volume is decreased in the brain of patients with neuromyelitis optica","volume":"20","author":"Chanson","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2017.02.003_bib5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00234-011-0875-x","article-title":"Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?","volume":"54","author":"Downer","year":"2012","journal-title":"Neuroradiology"},{"key":"10.1016\/j.msard.2017.02.003_bib6","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1016\/j.ejrad.2011.01.065","article-title":"Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: a voxel-based morphometry study","volume":"81","author":"Duan","year":"2012","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.msard.2017.02.003_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-9-14","article-title":"Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients","volume":"9","author":"Jarius","year":"2012","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.msard.2017.02.003_bib8","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jns.2014.07.035","article-title":"In vivo assessment of white matter damage in neuromyelitis optica: a diffusion tensor and diffusion kurtosis MR imaging study","volume":"345","author":"Kimura","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2017.02.003_bib9","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","article-title":"Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype","volume":"79","author":"Kitley","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2017.02.003_bib10","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","article-title":"Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study","volume":"71","author":"Kitley","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.msard.2017.02.003_bib11","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/ene.12058","article-title":"Long-term MRI findings in neuromyelitis optica: seropositive versus seronegative patients","volume":"20","author":"Kiyat-Atamer","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2017.02.003_bib12","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2017.02.003_bib13","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1177\/1352458511431731","article-title":"A tract-based diffusion study of cerebral white matter in neuromyelitis optica reveals widespread pathological alterations","volume":"18","author":"Liu","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2017.02.003_bib14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000352034","article-title":"Anti-aquaporin-4 antibody positivity in neuromyelitis optica is associated with lesion activity","volume":"70","author":"Liu","year":"2013","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.msard.2017.02.003_bib15","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1212\/WNL.0000000000001441","article-title":"Differential patterns of spinal cord and brain atrophy in NMO and MS","volume":"84","author":"Liu","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2017.02.003_bib16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1742-2094-8-184","article-title":"Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders","volume":"8","author":"Mader","year":"2011","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.msard.2017.02.003_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jns.2010.01.009","article-title":"Reappraisal of brain MRI features in patients with multiple sclerosis and neuromyelitis optica according to anti-aquaporin-4 antibody status","volume":"291","author":"Matsushita","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2017.02.003_bib18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00415-008-0545-z","article-title":"Preferential spinal central gray matter involvement in neuromyelitis optica. An MRI study","volume":"255","author":"Nakamura","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2017.02.003_bib19","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.neuroimage.2011.02.046","article-title":"A Bayesian model of shape and appearance for subcortical brain segmentation","volume":"56","author":"Patenaude","year":"2011","journal-title":"NeuroImage"},{"key":"10.1016\/j.msard.2017.02.003_bib20","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1177\/1352458511431072","article-title":"Advanced magnetic resonance imaging of neuromyelitis optica: a multiparametric approach","volume":"18","author":"Pichiecchio","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2017.02.003_bib21","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/archneur.63.3.390","article-title":"Brain abnormalities in neuromyelitis optica","volume":"63","author":"Pittock","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.msard.2017.02.003_bib22","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \"McDonald Criteria\"","volume":"58","author":"Polman","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2017.02.003_bib23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12974-015-0256-1","article-title":"Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype","volume":"12","author":"Probstel","year":"2015","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.msard.2017.02.003_bib24","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/1352458515593406","article-title":"Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis","author":"Ramanathan","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2017.02.003_bib25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1148\/radiol.12111241","article-title":"The role of demyelination in neuromyelitis optica damage: diffusion-tensor MR imaging study","volume":"263","author":"Rueda Lopes","year":"2012","journal-title":"Radiology"},{"key":"10.1016\/j.msard.2017.02.003_bib26","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1212\/WNL.56.10.1313","article-title":"Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients","volume":"56","author":"Schwarz","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2017.02.003_bib27","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/nimg.2002.1040","article-title":"Accurate, robust, and automated longitudinal and cross-sectional brain change analysis","volume":"17","author":"Smith","year":"2002","journal-title":"NeuroImage"},{"key":"10.1016\/j.msard.2017.02.003_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1155\/2006\/586306","article-title":"NMO-IgG: a specific biomarker for neuromyelitis optica","volume":"22","author":"Weinshenker","year":"2006","journal-title":"Dis. Markers"},{"key":"10.1016\/j.msard.2017.02.003_bib29","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1212\/WNL.0b013e31826aadaf","article-title":"Antibodies to MOG in NMO: a seasoned veteran finds a new role","volume":"79","author":"Willison","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2017.02.003_bib30","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2017.02.003_bib31","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2017.02.003_bib32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/cns.12156","article-title":"Clinical features and sera anti-aquaporin 4 antibody positivity in patients with demyelinating disorders of the central nervous system from Tianjin, China","volume":"20","author":"Yang","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.msard.2017.02.003_bib33","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1177\/1352458513499420","article-title":"Comparison of deep gray matter lesions on magnetic resonance imaging among adults with acute disseminated encephalomyelitis, multiple sclerosis, and neuromyelitis optica","volume":"20","author":"Zhang","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2017.02.003_bib34","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1177\/1352458515576982","article-title":"Cognitive impairment in Chinese neuromyelitis optica","volume":"21","author":"Zhang","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2017.02.003_bib35","first-page":"270","article-title":"Relationship between neuromyelitis optica-IgG status and spinal cord magnetic resonance imaging in patients with neuromyelitis optica","volume":"125","author":"Zhong","year":"2012","journal-title":"Chin. Med. J."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034817300184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034817300184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:39:15Z","timestamp":1761899955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034817300184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":35,"alternative-id":["S2211034817300184"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2017.02.003","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of brain and spinal cord magnetic resonance imaging features in neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2017.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}